Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer (Q56965679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

tertiary lymphoid structure

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alice Lepelley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sandrine Katsahian

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Isabelle Cremer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wolf Hervé Fridman

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Catherine Sautès-Fridman

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

8

Etienne Becht

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

Sacha Gnjatic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Claire Germain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Fella Tamzalit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Samantha Knockaert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Romain Remark

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Geoffray Bizouard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Pierre Validire

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Diane Damotte

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Marco Alifano

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Pierre Magdeleinat

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jean-Luc Teillaud

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Marie-Caroline Dieu-Nosjean

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

832-844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

CD20+ B cells: the other tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

B cells as antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Humoral immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Lymphoid organ development: from ontogeny to neogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Tertiary lymphoid organs in infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Autoantibodies against cancer antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

New insights into the development of lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Analysis of somatic mutation in five B cell subsets of human tonsil

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

The germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1611OC

10.1164/RCCM.201309-1611OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24484236%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference